Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Type

Label

Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Note

Title from title screen (viewed on May 29, 2008)"For release ... April 22, 2008."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548

Acquisition source address

GAO (202)512-6000 (voice); (202)512-6061 (Fax); (202)512-2537 (TDD)

Color

mixed

Form Of Item

online

resource.govDocClassificationNumber

GA 1.5/2:GAO-08-701 T

resource.gpoItemNumber

0546-D-01 (online)

Physical Description

19 pages, digital, PDF file.

Specific Material Designation

remote

System control number

(Sirsi) o232330615

System details

Mode of access: Internet from GPO Access web site. Address as of 5/29/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d08701t.pdf; current access available via PURL

Instantiates